Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-28,560
Closed -$191K 10285
2024
Q4
$191K Buy
28,560
+25,739
+912% +$227K ﹤0.01% 8444
2024
Q3
$28.4K Sell
2,821
-22,210
-89% -$324K ﹤0.01% 9256
2024
Q2
$390K Buy
+25,031
New +$419K ﹤0.01% 7412
2024
Q1
Sell
-4,077
Closed -$78.9K 9838
2023
Q4
$78.9K Buy
+4,077
New +$74.4K ﹤0.01% 8667
2023
Q2
Sell
-11,068
Closed -$320K 9315
2023
Q1
$320K Buy
+11,068
New +$295K ﹤0.01% 7079
2022
Q3
Sell
-1,049
Closed -$58K 10227
2022
Q2
$58K Sell
1,049
-2,351
-69% -$86.5K ﹤0.01% 8879
2022
Q1
$126K Buy
+3,400
New +$121K ﹤0.01% 9339

Other funds holding OPTN

Jane Street's OPTN Position: Q1 2025 in Review

Jane Street sold out of OptiNose (OPTN) in Q1 2025, closing a stake of 28,560 shares — an estimated $191K sold.

Jane Street first reported a position in OPTN in Q1 2022 and held it in 7 quarters. The position peaked at $390K in Q2 2024. 43 funds tracked by Wall St. Rank hold OPTN as of Q1 2025.

  • Jane Street reported no remaining OptiNose position as of Q1 2025 after selling out during the quarter.
  • Jane Street sold 28,560 OptiNose shares in Q1 2025, an estimated $191K.
  • Jane Street first reported a position in OptiNose in Q1 2022 and held it in 7 quarters.
  • Jane Street's OptiNose position peaked at $390K in Q2 2024.
  • 43 funds tracked by Wall St. Rank held OptiNose as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.